EraGen is expanding facilities to further develop its discovery and therapeutic research in nucleic acid as well as bioinformatics technology. The new space, located in the new Biotechnology Center built by the Gialamas Co. in Old Sauk Trails, offers state-of-the-art nucleic acid facilities including a discovery research laboratory, organic chemistrysynthesis, molecular recognition using advanced robotics and optical technologies, GMP & ISO manufacturing and handling of biohazardous material.
The new building also offers a world-class bioinformatics facility to greatly increase the data processing speeds.
"The additional space will allow EraGen to continue its rapid growth in the discovery marketplace and maintain its excellence in cutting-edge technology," says Dr. Gary A. Alianell, EraGen's chief operating officer.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
